WASHINGTON, May 6, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended April 3, 2020. All results in this release reflect only continuing operations unless otherwise noted. For the first quarter 2020, net earnings were $595.1 million, or $0.81 per diluted common share. Non-GAAP adjusted diluted net earnings... Read more
Q1 2020 results: Net sales of $372.1 million (+7% actual, +9% CER vs. ~+2-3% CER outlook) Diluted EPS $0.17; adjusted EPS $0.34 ($0.34 CER vs. ~$0.28-0.29 CER outlook) Fully mobilized teams addressing COVID-19 pandemic testing demand, dramatically ramping up production of RNA extraction kits, QIAstat-Dx tests and components for third-party tests QIAGEN expects higher results... Read more
MENLO PARK, Calif., May 06, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2020.As previously announced, in January 2020, we and Illumina mutually agreed to terminate the Agreement and Plan of Merger (as amended, the “Merger Agreement”). As part of our... Read more
Highest level of AOAC approval includes testing for foods such as romaine lettuce, raw salmon, dairy products and herbs and spices WALTHAM, Mass. – May 6, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its Solus One™ Salmonella assay and methods have been granted First Action Official... Read more
Revenue of $652.4 million; 1% reported growth; (1)% organic growth GAAP EPS from continuing operations of $0.30; Adjusted EPS of $0.67 Withdrawing previously disseminated FY20 guidance due to COVID-related uncertainties WALTHAM, Mass.–(BUSINESS WIRE)–May 5, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the... Read more
Reported net income of $38 million or $0.21 per share; adjusted net income of $42 million or $0.23 per share Organic revenue declined 8% in the first quarter, impacted by COVID-19; declined 9% on a reported basis Maintaining strong balance sheet, ~$1.7 billion of available liquidity RYE BROOK, N.Y.–(BUSINESS WIRE)–May 5, 2020– Xylem Inc. (NYSE:... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina (NASDAQ: ILMN) today announced the appointment of Alex Aravanis as Chief Technology Officer. Dr. Aravanis will be responsible for leading Illumina’s research and technology development functions and the innovation engine for next-generation sequencing platforms and applications, accelerating technology breakthroughs and translation to the clinic. Dr. Aravanis will join Illumina in early June... Read more
EDEN PRAIRIE, Minn., May 4, 2020 /PRNewswire/ — MTS Systems Corporation (Nasdaq: MTSC), a leading global supplier of high-performance test systems, motion simulators and sensors, today reported financial results for its fiscal year 2020 second quarter ended March 28, 2020. SECOND QUARTER FINANCIAL AND OPERATING HIGHLIGHTS Record orders of $277.4 million, an increase of 31.1%, reflecting record orders... Read more
Delivers Accelerated Organic Growth and Return to Profitability AUSTIN, Texas, May 4, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its first quarter ended March 31, 2020. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). CURRENT HIGHLIGHTS Total revenue for the first quarter of $90.4M,... Read more
The serology test has a specificity greater than 99.8% and sensitivity of 100% (14 Days post-PCR confirmation) The high specificity of the test is crucial to determine reliably if a person has been exposed to the virus and if the patient has developed antibodies Roche will provide high double-digit millions of tests already in May... Read more